Progress in the Development of Poliovirus Antiviral Agents and Their Essential Role in Reducing Risks That Threaten Eradication

Anti-poliovirus activity of protease inhibitor AG-7404, and assessment of in vitro activity in combination with antiviral capsid inhibitor compounds

(2013) Eric Rhoden et al.   ANTIVIRAL RESEARCH

Characterization of Poliovirus Variants Selected for Resistance to the Antiviral Compound V-073

(2012) Hong-Mei Liu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073

(2011) Diana V Kouiavskaia et al.   ANTIVIRAL THERAPY

Immunogenicity of Inactivated Polio Vaccine with Concurrent Antiviral V-073 Administration in Mice

(2011) Diana Kouiavskaia et al.   Clinical and Vaccine Immunology

Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis

(2011) Z. Chen et al.   JOURNAL OF VIROLOGY

In Vitro Antiviral Activity of V-073 against Polioviruses

(2009) M. S. Oberste et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A case for developing antiviral drugs against polio

(2008) Marc S. Collett et al.   ANTIVIRAL RESEARCH

Changes in Population Dynamics during Long-Term Evolution of Sabin Type 1 Poliovirus in an Immunodeficient Patient

(2008) J. K. Odoom et al.   JOURNAL OF VIROLOGY